Diabetes Mellitus, Type 2 clinical trials
Access comprehensive clinical trial information for Diabetes Mellitus, Type 2 through Pure Global AI's free database. This collection includes 1,659 clinical trials across multiple phases including N/A, Phase 3, Phase 1. Currently, 164 trials are actively recruiting participants.
Research for Diabetes Mellitus, Type 2 is being conducted in United States of America, China, Germany and 7+ other countries. Leading sponsors include Novo Nordisk A/S and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 1,659 clinical trials studying Diabetes Mellitus, Type 2, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Novo Nordisk A/S, Eli Lilly and Company, Boehringer Ingelheim, among others.